We provide you with 20 years of free, institutional-grade data for AMYT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AMYT. Explore the full financial landscape of AMYT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about AMYT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Amryt Pharma plc(NASDAQ:AMYT) 
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the compl...
Website: https://www.amrytpharma.com
Founded: 2004
Full Time Employees: 289
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Share this website to your friends